Nevirapine Resistance Mutation at Codon 181 of the HIV-1 Reverse Transcriptase Confers Stavudine Resistance by Increasing Nucleotide Substrate Discrimination and Phosphorolytic Activity
Open Access
- 1 May 2003
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (18), 15469-15472
- https://doi.org/10.1074/jbc.c300022200
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Combinations Against Combinations: Associations of Anti-HIV 1 Reverse Transcriptase Drugs Challenged by Constellations of Drug Resistance MutationsCurrent Drug Metabolism, 2002
- Thymidine Analog and Multinucleoside Resistance Mutations Are Associated with Decreased Phenotypic Susceptibility to Stavudine in HIV Type 1 Isolated from Zidovudine-Naive Patients Experiencing Viremia on Stavudine-Containing RegimensAIDS Research and Human Retroviruses, 2001
- Low-Rate Emergence of Thymidine Analogue Mutations and Multi-Drug Resistance Mutations in the HIV-1 Reverse Transcriptase Gene in Therapy-Naive Patients Receiving Stavudine plus Lamivudine Combination TherapyAntiviral Therapy, 2001
- Nucleoside Reverse Transcriptase Inhibitor ResistanceJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Molecular mechanisms of HIV-1 resistance to nucleoside reverse transcriptase inhibitors (NRTIs)Cellular and Molecular Life Sciences, 2000
- A Family of Insertion Mutations between Codons 67 and 70 of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Confer Multinucleoside Analog ResistanceAntimicrobial Agents and Chemotherapy, 1999
- Resistance to nevirapine of HIV-1 reverse transcriptase mutants: loss of stabilizing interactions and thermodynamic or steric barriers are induced by different single amino acid substitutionsJournal of Molecular Biology, 1997
- Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapyJournal of Virology, 1996
- Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides.Proceedings of the National Academy of Sciences, 1995